An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis

Suppah, Mustafa; Kamal, Abdallah; Saadoun, Rakan; Baradeiya, Ahmed M.A.; Abraham, Bishoy; Alsidawi, Said; Sorajja, Dan; Fortuin, F. David; Arsanjani, Reza

doi:10.1016/j.amjcard.2023.07.141

Cited by 5 publications

(1 citation statement)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DOACs are oral anticoagulants that can directly inhibit thrombin and factor Xa, with a biological half-life of almost half a day. DOACs are available in once- or twice-daily dosing regimens and are used for the prevention of embolism from NVAF and venous thromboembolism [ 36 ]. Dabigatran, a thrombin inhibitor, is not indicated for venous thromboembolism (Table 2 ).…”

Section: Reviewmentioning

confidence: 99%

Understanding Antithrombotic Agents for Rehabilitation Therapy: A Comprehensive Narrative Review

Matsumoto,

Ohama,

Hoei

et al. 2024

Cureus

View full text Add to dashboard Cite

In rehabilitation medicine, attention must be paid to the medication. Among them, antithrombotic drugs are used for the initial treatment and secondary prevention of stroke, so as a basic knowledge, the pharmacological actions, characteristics, indications, and precautions for the use of antithrombotic drugs should be known. Antithrombotic agents are divided into antiplatelet agents and anticoagulants, and the appropriate antithrombotic agent is selected according to the main disease or condition. Antiplatelet agents include aspirin, clopidogrel, ticlopidine, prasugrel, ticagrelor, and cilostazol. Each antiplatelet agent has a different mechanism of action, characteristics, and indications, and should be prescribed with due consideration. Anticoagulants include heparin, synthetic Xa inhibitors, direct oral anticoagulants (DOACs), synthetic antithrombin agents, and warfarin. Knowledge of the mechanism of action, characteristics, and indications of each anticoagulant is necessary, as well as monitoring and dose adjustment. With regard to ischemic cerebrovascular disease (ICD) and antithrombotic agents, the first step is to classify cerebral infarction and to determine whether antiplatelet agents or anticoagulants should be used. Bleeding and recurrence prevention are important considerations in the selection of appropriate antithrombotic agents for the pathophysiology of ICD.

show abstract

Section: Reviewmentioning

confidence: 99%